RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,590 | +21.0% | 530 | -0.7% | 0.00% | – |
| Q2 2023 | $1,314 | -89.2% | 534 | -90.0% | 0.00% | – |
| Q1 2023 | $12,125 | +204.0% | 5,365 | +369.4% | 0.00% | – |
| Q4 2022 | $3,989 | -99.8% | 1,143 | -98.3% | 0.00% | – |
| Q3 2022 | $2,460,000 | +187.4% | 66,453 | +47.6% | 0.00% | – |
| Q2 2022 | $856,000 | +30.9% | 45,032 | +85.9% | 0.00% | – |
| Q1 2022 | $654,000 | +246.0% | 24,230 | +188.8% | 0.00% | – |
| Q4 2021 | $189,000 | +472.7% | 8,389 | +559.0% | 0.00% | – |
| Q3 2021 | $33,000 | -89.2% | 1,273 | -86.7% | 0.00% | – |
| Q2 2021 | $306,000 | -29.5% | 9,545 | -22.5% | 0.00% | – |
| Q1 2021 | $434,000 | -68.6% | 12,312 | -71.5% | 0.00% | – |
| Q4 2020 | $1,383,000 | +5.3% | 43,134 | +23.4% | 0.00% | – |
| Q3 2020 | $1,314,000 | -24.7% | 34,945 | -10.3% | 0.00% | -100.0% |
| Q2 2020 | $1,744,000 | +337.1% | 38,958 | +233.4% | 0.00% | – |
| Q1 2020 | $399,000 | +0.8% | 11,685 | +15.0% | 0.00% | – |
| Q4 2019 | $396,000 | – | 10,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |